Skip to main content
. 2008 May 14;3(5):e2159. doi: 10.1371/journal.pone.0002159

Figure 4. Seropositivity/seroprotection rates for other antigens (D*, T, P, HBV) after primary vaccination (Post-dose III) and before the polysaccharide challenge (Pre-challenge) (ATP cohort for persistence for diphtheria, ATP cohort for immunogenicity for post-dose III).

Figure 4

Footnote: Error bars represent 95%CI.